Kaira Can Company manufactures metal containers and open-top sanitary cans for the food, dairy, and paint industries, and also produces rolled sugar cones for ice cream manufacturers.
The company lacks a durable moat as evidenced by low average net margins of 2.6% and ROCE below 10%. While it has long-standing relationships with major cooperatives like GCMMF, its products are largely commodities subject to intense competition from the unorganized sector and alternative packaging materials.
Management has focused on incremental capacity expansion and technological upgrades, such as new printing lines and cone machines. However, these investments have not translated into EPS growth, which has declined at a CAGR of -17.4% over the period.
The business succumbed to the 'commodity trap' where rising input costs met a dominant, price-sensitive customer base that refused to yield margin. Despite revenue growth, the structural inability to pass on costs led to continued earnings erosion, mirroring the historical -17.4% EPS CAGR. The lack of pricing power, combined with a shift toward alternative packaging materials and a volatile export market, eventually turned the thin 2.6% net margins into persistent losses, leaving the company as a value-destroying 'cigar butt' with no remaining puffs.
RichFakir rates Kaira Can Company Ltd's business quality as poor — 39/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Kaira Can Company Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Kaira Can Company Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Kaira Can Company Ltd's fair value is about ₹583 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →